Pharmafile Logo
Pharmafocus logo
Advanced Search

dementia

Showing 15 posts of 58 posts found.

hands-981400_960_720

Common antidepressants linked to dementia risk

April 26, 2018
Medical Communications anticholinergic, biotech, dementia, drugs, pharma, pharmaceutical

A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …

News
brain-1787622_640

Antiepileptic drug use linked to increased risk of Alzheimer’s and dementia

April 10, 2018
Manufacturing and Production, Research and Development Alzheimer's disease, dementia, epilepsy, pharma

A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases (DZNE) has revealed …

News
bi_microparts_image

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018
Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …

News
biology-think-networking-physiology-brain-anatomy-2676370

Axovant’s drug bested by placebo, shares reduced to dust

January 8, 2018
Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical

The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …

News
brain-770044_960_720

‘Brain training’ found to reduce risk of dementia by 29%

November 22, 2017
Research and Development biotech, dementia, drugs, pharma, pharmaceutical

In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …

News
alzheimers_brain

Over-the-counter multinutrient drink could have beneficial impact on Alzheimer’s, new study reveals

October 31, 2017
Manufacturing and Production, Research and Development Alzheimer's, Fortasyn Connect, Souvenaid, dementia

LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …

News
8384110298_da510e0347_c

Research finds blood-thinners protect against dementia

October 25, 2017
Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …

News
alzheimers-749616_960_720

Alzheimer’s disease: Fighting back against a growing threat

September 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

Feature
shutterstock_311949818

Stomach acid drugs do not increase Alzheimer’s risk, study confirms

August 7, 2017
Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

News
tau_tangle

Atomic structure of tau revealed opening up new Alzheimer’s targets

July 6, 2017
Research and Development Alzheimer's disease, dementia, tau protein, tau tangle

It is a research breakthrough that has been touted as the biggest development in Alzheimer’s disease research for a quarter …

News
cuba

Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s

May 16, 2017
Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia

The health care system in Cuba is widely held up to be a model of innovation; despite severe economic  sanctions …

News
nursing_home

Behavioural intervention reduces need for antipsychotics in dementia treatment

April 19, 2017
Research and Development antipsychotic, dementia

A new study has suggested that dementia patients may not require as high a dosage of antipsychotic medication that was …

News
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016
Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …

News
heptares_logo

Heptares announces positive early-stage dementia trial results

February 10, 2016
Research and Development Alzheimer's, Alzheimers, Heptares, dementia, schizophrenia

Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for …

News
Brain scan

Lilly and Roche team up on new Alzheimer’s diagnostic test

January 28, 2016
Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly

Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023